NCT05604365View on ClinicalTrials.gov

FearLess in Cognitively Intact Patients With Glioma

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

November 14, 2023

Study Completion Date

November 14, 2023

Conditions
GliomaFear of Cancer
Interventions
BEHAVIORAL

FearLess Intervention

8-12 weekly telehealth sessions one hour in length.The intervention includes psychotherapy techniques varying from relaxation response to self-regulation targeted to the specific fears of patients with glioma.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER